Type of Manuscripts

The Nigerian Journal of Pharmaceutical and Applied Science Research is an international Open Access journal devoted to the promotion of pharmaceutical sciences and related disciplines (including biotechnology, cell and molecular biology, drug utilization including adverse drug events, medical and other life sciences, and related engineering fields). It seeks particularly (but not exclusively) to encourage pharmaceutical and allied research of tropical relevance and to foster multidisciplinary research and collaboration among scientists, the pharmaceutical industry and healthcare professionals. It also provides an international forum for the communication and evaluation of data, methods and findings in pharmaceutical sciences and related disciplines. Although primarily devoted to original research papers, the journal welcomes reviews on current topics of special interest and relevance.

All manuscripts are subject to rapid peer review. Those of high quality (not previously published and not under consideration for publication in another journal) are published without delay.

The maximum length of manuscripts should be 6000 words (24 double-spaced typewritten pages) for review, 4000 words (18 pages) for research articles, and 1,500 (6 pages) for technical notes, commentaries and short communications.

 

Submission of Manuscript

All manuscripts (must be in English and MS Word format) and should be submitted via our online system. The e-mail addresses (or telephone numbers) of all authors must be provided. Illustrations (figures) should be in computer format. Images for any manuscript should not exceed 200 kilobytes unless prior authorization is received from the editor-in-chief. Authors may submit the names, affiliations and addresses (including e-mail) of expert reviewers or those they do not want to review their papers.

This journal does not accept manuscripts that are simultaneously being considered by another or other journals or have already been published elsewhere. Thus, authors are required to include the following statement in the Comments to the Editor:

"This manuscript submitted has not been previously published, nor is it before another journal for consideration"

NIJOPHASR subscribes to 'Standards for Authors available at http://publicationethics.org/international-standards-editors-and-authors or http://www.ncbi.nlm.nih.gov/)

Ethical Matters

Authors using experimental animals and human subjects in their investigation must seek approval from the appropriate Ethical Committee under "Principles of Laboratory Animal Care" (NIH publication no. 85-23, revised 1985) and/or the declaration of Helsinki promulgated in 1964 as amended in 1996. The method section must include a statement to prove that the investigation was approved and that informed consent was obtained.

Manuscript Format

The preferred format of all manuscripts is MS Word or RTF. Illustrations (figures) and images must be inserted in the manuscript at the position they should appear when published.

 

CLICK HERE TO DOWNLOAD A TEMPLATE

Manuscript charges

Manuscript submission: There is no charge for submitting a manuscript.

Publication charge: Once a manuscript is accepted for publication, the author(s) will be required to pay a publication charge of US$100.00 before the accepted paper is published. Authors may opt for fast-track (accelerated) review and publication which attracts a special publication charge of US$200.00 if the manuscript is accepted for publication. Manuscripts that fall under the fast-track option would be published, if accepted for publication, within 4 - 5 months from the time they are sent for review while those on the normal track may take a much longer period.

Copyright

Submission of a manuscript to this journal is a representation that the manuscript has not been published previously and is not under consideration for publication elsewhere.

All authors named in each manuscript would be required to sign a form (to be supplied by the Editor) so that they may retain their copyright in the article but to assign to us (the Publishers) and its licensees in perpetuity, in all forms, formats and media (whether known or created in the future) to (i) publish, reproduce, distribute, display and store the contribution, (ii) translate the Contribution into other languages, create adaptations, reprints, include within collections and create summaries, extracts and/or abstracts of the contribution, (iii) create any other derivative works(s) based on the contribution, (iv) to exploit all subsidiary rights in the contribution, (v) the inclusion of electronic links from the contribution to third party material where-ever it may be located, and (vi) license any third party to do any or all of the above.

Ethical Matters

Authors using experimental animals and human subjects in their investigation must seek approval from the appropriate Ethical Committee under "Principles of Laboratory Animal Care" (NIH publication no. 85-23, revised 1985) and/or the declaration of Helsinki promulgated in 1964 as amended in 1996. The method section must include a statement to prove that the investigation was approved and that informed consent was obtained.

Galley Proofs

Unless indicated otherwise, galley proofs are sent to the address given for correspondence. It is the responsibility of the corresponding author to ensure that the galley proofs are returned without delay.

MANUSCRIPT SUBMISSION CHECK-LIST

Please carefully go through the following checklist. Non-compliance with NIJOPHASR manuscript formatting requirements will result in the manuscript being returned to the corresponding author for reformatting or rejection.
[ ] Is my manuscript typed double-spaced on A4 (MS Word 2003 or earlier version) including the Abstract and References sections? Note that PDF is not acceptable.
[ ] Are the Title and Abstract each on separate pages?
[ ] Is the Abstract (except for review manuscripts) subdivided into the prescribed subsections of Purpose, Methods, Results and Conclusion, and also within the 250-word limit?
[ ] Is my manuscript within the limit of 4,000 words (approximately 18 pages typed double-spaced on A4) for research papers or 6,000 words (approximately 24 pages typed double-spaced on A4) for review papers?
[ ] Are Results and Discussion separated into two sections of Results and Discussion?
[ ] Is there a Conclusion section?
[ ] Have you provided the Declarations including (1) Acknowledgement, (2) Conflict of Interest and (3) Contribution of Authors as provided in the guidelines for contributors?
[ ] Is the reference numbering style within text co-script with square parenthesis (squared brackets) with the numbers inserted before and not after punctuations?
[ ] Did the References list adhere strictly to NIJOPHASR format, including the correct punctuations and with space after semi-colon, colon and comma?
[ ] Is the total number of Figures and Tables within the limit of 9 allowed?
[ ] Has color (other than black) been excluded from the manuscript including graphs (except photomicrographs)?
[ ] Is there a legend/caption at the bottom of each Figure and at the top of each Table?
[ ] Have you ensured that when each figure/image is reduced to occupy no more than three-quarters of half of an A4 column in a page, the font size of labels will not be smaller than 9 points?
[ ] Is the symbol key removed from within the Figure (graphs) and integrated neatly within the legend using the Symbol tool under Insert menu of MS Word ? Do not place horizontal strokes across symbols.
[ ] Have borders been removed from around the Figures?
[ ] Are Figures and Tables inserted at appropriate points in the manuscript nearest to where references were made to them?
[ ] Are Figures and Tables referred to independently, ie, you have not referred to more than one Table (eg Tables 1-3) in the text?
[ ] Have you read and adhered strictly to our policy statements?